Lantern Pharma

Clinical stage biotechnology companyLantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. It develops LP-100 for treatment in combination with the class of anticancer agent known as PARP inhibitors.Country: United StatesIndustry: BiotechnologyIPO Date: Jun 11, 2020Sector: Healt...